<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>ClinicalKey Latest Issue: Annals of Allergy, Asthma &amp; Immunology</title>
    <link>https://www.clinicalkey.com/dura/browse/journalIssue/10811206</link>
    <description>Content from the latest issue of Annals of Allergy, Asthma &amp; Immunology.</description>
    <atom:link href="https://cdn.clinicalkey.com/rss/issue/10811206.xml" type="application/rss+xml" rel="self" />
    <item>
      <title>From the pages of AllergyWatch</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002942</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 406-408 | Joshi, Shyam R., MD; Fineman, Stanley M., MD; Lee, Gerald B., MD;...&lt;br/&gt;For this edition of “From the pages of AllergyWatch”, I have selected articles from recent issues of AllergyWatch related to shared decision-making. The first article is from the Journal of the American Medical Association on the development of a ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002942</guid>
    </item>
    <item>
      <title>Remibrutinib impact on disease control, sleep, and quality of life</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002711</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 349-356.e5 | Mosnaim, Giselle, MD; Saini, Sarbjit, MD; Lebwohl, Mark, MD;...&lt;br/&gt;AbstractBackgroundChronic spontaneous urticaria (CSU) substantially reduces patients' quality of life (QoL); therefore, it is crucial to include QoL-related patient-reported outcome measures when assessing treatment efficacy. ObjectiveTo evaluate ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002711</guid>
    </item>
    <item>
      <title>Shared decision-making and integrative medicine in the allergist’s office</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626000979</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 272-273 | Soffer, Gary K., MD; Marshall, Gailen D., MD, PhD&lt;br/&gt;“Integrative medicine is just good medicine.”—Andrew Weil The health care landscape has seen a seismic shift in the past several years in many areas of practice. There is growing concern about many aspects of conventional medical care and increasi...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626000979</guid>
    </item>
    <item>
      <title>Guidelines and shared decision-making for disruptive innovations in allergy</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626000542</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 274-275 | Golden, David B.K., MDCM&lt;br/&gt;Innovation can be so disruptive. OFC, OIT, SLIT, SMART: OMG! And now nasal epinephrine? We are not in Kansas anymore. Innovations are described as “disruptive” when they recognize and fill a gap in existing products or technologies in such a succe...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626000542</guid>
    </item>
    <item>
      <title>Patient and caregiver perspectives on threshold-based precautionary allergen labeling</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002000</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 362-367.e2 | Madireddy, Shreaya, BS; Milliron, Chloe, BS; Wong, Sharon, Med;...&lt;br/&gt;AbstractBackgroundPrecautionary allergen labeling (PAL), such as “may contain” statements, remains unregulated in the United States, despite its widespread use and importance for individuals with food allergies. ObjectiveTo explore the perspective...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002000</guid>
    </item>
    <item>
      <title>Improved asthma outcomes with dupilumab plus medium-dose inhaled corticosteroids vs placebo plus high-dose inhaled corticosteroids</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002231</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 320-328 | Busse, William W., MD; Castro, Mario, MD; Lugogo, Njira L., MD;...&lt;br/&gt;AbstractBackgroundEscalating from medium-dose inhaled corticosteroid (ICS) to high-dose ICS in patients with asthma offers limited clinical benefit. ObjectiveTo assess the advantages of adding dupilumab to medium-dose ICS vs continuing high-dose I...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002231</guid>
    </item>
    <item>
      <title>American College of Allergy, Asthma and Immunology (ACAAI)/American Academy of Pediatrics (AAP) symposium—What was served in the past year: Food allergy nontreatment</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002164</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 314-317 | Bingemann, Theresa A., MD&lt;br/&gt;AbstractFood allergies are increasing, with 1 of 13 children in the United States affected. This article discusses articles chosen by the author for inclusion in the American College of Allergy, Asthma and Immunology/American Academy of Pediatrics...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002164</guid>
    </item>
    <item>
      <title>Depemokimab reduces asthma exacerbations similarly to other biologics</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002188</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 329-339.e7 | Bourdin, Arnaud, MD; Pavord, Ian D., FMedSci; Ballew, Nicholas, PhD;...&lt;br/&gt;AbstractBackgroundDepemokimab is the first ultra–long-acting biologic, with efficacy and safety recently reported in the Phase III SWIFT-1/-2 studies, which included patients with type 2 asthma. ObjectiveTo estimate the relative efficacy and safet...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002188</guid>
    </item>
    <item>
      <title>Safety and efficacy of three office-based egg oral immunotherapy protocols</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002401</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 357-361 | Buckey, Timothy M., MD, MBE; Giannì, Giuliana, MD; Hanna, Elizabeth, MSN, RN, CPNP;...&lt;br/&gt;AbstractBackgroundEgg allergy is one of the most common IgE-mediated food allergies. There is no treatment approved by the US Food and Drug Administration that allows the liberalization of egg into the diet. Studies have shown that oral immunother...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002401</guid>
    </item>
    <item>
      <title>After the escalator</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002310</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 300-313 | Gronnier, Morgane, MD; Ramakrishnan, Sanjay, MD, PhD; Beasley, Richard W., DSc;...&lt;br/&gt;AbstractAsthma, the most common chronic respiratory disease, is characterized by variable symptoms, airflow limitation, and airway inflammation. Current management relies largely on a symptom-focused stepwise escalation approach, which often leads...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002310</guid>
    </item>
    <item>
      <title>Nonsteroidal anti-inflammatory drugs in the treatment of uterine anaphylaxis</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002656</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 398-401 | Luu, Janet, DO; Abud, Edsel, MD, PhD; Namazy, Jennifer, MD;...&lt;br/&gt;Uterine anaphylaxis, or anaphylaxis presenting with severe uterine cramping or contractions, is a rare manifestation of anaphylaxis in females, categorized as grade 3 by the World Allergy Organization. Although the literature is limited regarding ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002656</guid>
    </item>
    <item>
      <title>Unique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002619</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 340-348.e3 | Minichetti, Dante G., BA; Dharia, Tiffany, MD; Boyd, Amelia, BA;...&lt;br/&gt;AbstractBackgroundPersistent chemosensory dysfunction (CSD) occurs in both COVID‑19 and aspirin-exacerbated respiratory disease (AERD). The similarities and differences in the chemosensory experiences of these 2 conditions remain undefined and poo...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002619</guid>
    </item>
    <item>
      <title>Communication, compassion, and shared decision-making in allergy</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001171</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 282-290 | Abrams, Elissa M., MD, MPH, FRCPC, FAAAAI&lt;br/&gt;AbstractShared decision-making (SDM) is a structured approach to clinical care that integrates the best available evidence, clinician expertise, and patient values. Although SDM frameworks are well described, comparatively little attention has bee...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001171</guid>
    </item>
    <item>
      <title>Predictors for T cell receptor excision circles in infants without severe combined immunodeficiency or thymic aplasia/hypoplasia</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001225</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 380-386.e3 | Navalpakam, Aishwarya, MD; Hurden, Isabel, MPH; Lugt, Mark Vander, MD;...&lt;br/&gt;AbstractBackgroundAlthough developed to identify severe combined immunodeficiency (SCID), T cell receptor excision circle (TREC)–based newborn screening also detects T cell lymphopenia of varying etiologies. ObjectiveTo identify perinatal factors ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001225</guid>
    </item>
    <item>
      <title>Racial differences in food allergy diagnostics</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001766</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 368-373.e1 | Detlor, Luke, BS; Bindon, Brittany, MD; Carr, Elizabeth, PhD;...&lt;br/&gt;AbstractBackgroundIn the United States, food allergy (FA) is more prevalent among Black children and adults than among White populations. The reason for this observed difference is unknown. ObjectiveTo propose that bias in FA testing contributes t...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001766</guid>
    </item>
    <item>
      <title>Enhanced clinical decision-making to optimize targeted gene panel testing for inborn errors of immunity</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001614</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 387-395.e9 | Udomkittivorakul, Natsumon, MD; Zhang, Jiahua, MD; Arora, Jyoti, MS;...&lt;br/&gt;AbstractBackgroundTargeted gene panels (TGPs) are frequently used to assess inborn errors of immunity (IEI) owing to the expanding knowledge of monogenic causes. Refining their clinical indications may enhance test yields. ObjectiveTo assess clini...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001614</guid>
    </item>
    <item>
      <title>Rapid drug desensitization in pediatric patients</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001997</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 374-379.e2 | Sze, Summer T.K.; Leung, Daniel, PhD; Nguyen, Alan A., MD;...&lt;br/&gt;AbstractBackgroundDrug hypersensitivity is often managed by drug desensitization, yet published data remain scarce in children. This study evaluated the safety and efficacy of rapid desensitization to chemotherapeutic agents, monoclonal antibodies...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001997</guid>
    </item>
    <item>
      <title>Precision medicine in atopic dermatitis</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002668</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 291-299 | Fonacier, Luz, MD; Mawhirt, Stephanie, DO; Stern, Heather, DO;...&lt;br/&gt;AbstractAtopic dermatitis (AD) is a chronic, multifactorial inflammatory skin disease characterized by barrier dysfunction, immune dysregulation, genetic predisposition, and environmental factors, including microbiome and allergens. As more is lea...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002668</guid>
    </item>
    <item>
      <title>Genetic testing for inborn errors of immunity: Improving the pretest probability</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002139</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 280-281 | Chinen, Javier, MD, PhD&lt;br/&gt;The recently updated practice parameters for inborn errors of immunity (IEI) discussed recommendations for genetic testing and reviewed the positive impact of genetic diagnosis in the management of IEI, acknowledging its increased accessibility in...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002139</guid>
    </item>
    <item>
      <title>Introducing the distinguished authors of 2026</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002644</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 269-269 | Grayson, Mitchell H., MD&lt;br/&gt;This year marks the third year of the Annals Distinguished Authors program. , Through the generosity of the American College of Allergy, Asthma and Immunology (ACAAI), Annals is able to honor those in the Allergy and Immunology field who have chan...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002644</guid>
    </item>
    <item>
      <title>Table of Contents</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003777</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages A3-A5&lt;br/&gt;(no summary available)</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003777</guid>
    </item>
    <item>
      <title>Editorial Board</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003789</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages A7-A7&lt;br/&gt;(no summary available)</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003789</guid>
    </item>
    <item>
      <title>Differential rates of oral food challenges among patients of different races</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002899</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 276-277 | Singh, Tarandeep, DO; Bingemann, Theresa A., MD&lt;br/&gt;Food allergy (FA) is a common and increasingly prevalent condition in the United States . Over the past 2 decades, racial disparities in FA have become increasingly apparent, with higher rates of self-reported FAs observed among racial and ethnic ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002899</guid>
    </item>
    <item>
      <title>Clinical communication, shared decision-making, and kindness as the penultimate therapeutic modality</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001274</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 270-271 | Shaker, Marcus S., MD, MS; Davis, Ray S., MD; Bukstein, Don, MD&lt;br/&gt;Clinical communication underpins medical care, with the clinician-patient relationship at its core. Shared decision-making (SDM), highlighted in this month’s Annals, is an important part of this process. SDM is one type of clinical communication, ...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626001274</guid>
    </item>
    <item>
      <title>Man’s best friend: A history</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002024</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 318-319 | Reigh, Erin L., MD, MS&lt;br/&gt;Unlabelled image dummy alt text Cartootorial: Patients with animal allergies often inquire about the efficacy of subcutaneous immunotherapy (SCIT) to help them tolerate a beloved pet. While SCIT for cat allergy has been shown to improve clinical o...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002024</guid>
    </item>
    <item>
      <title>Differences in gastrointestinal adverse event rates during oral immunotherapy</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002632</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 404-404 | Moraca, Payge, DO; Zhou, Guangying, BA, BS; Schaefer, Karla, RN;...&lt;br/&gt;We read, with interest, the article by Buckey et al, which evaluated the rates of gastrointestinal adverse events among patients undergoing oral immunotherapy (OIT) at the Children’s Hospital of Philadelphia. We performed a similar retrospective r...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002632</guid>
    </item>
    <item>
      <title>Information for Readers</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003765</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages A1-A1&lt;br/&gt;(no summary available)</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003765</guid>
    </item>
    <item>
      <title>Thoughts on the July issue of Annals</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003297</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 405-405 | Bellanti, Joseph A., MD&lt;br/&gt;I read with great interest the editorial by Spergel entitled, “Allergy Is More Than Type 2 Disease,” and the accompanying articles describing the overlap among atopic dermatitis, autoimmune disease, eosinophilic esophagitis, and inborn errors of i...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626003297</guid>
    </item>
    <item>
      <title>Longitudinal prescribing patterns of mammalian allergen immunotherapy across the US Military Health Care System from 2005 to 2024</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S108112062600267X</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 401-403 | Pepper, Elizabeth A., DO; Schornack, Brandon J., DO; Zamani, Michael, MS;...&lt;br/&gt;Mammalian allergens are clinically important triggers of allergic rhinoconjunctivitis and asthma, arising from both companion animal ownership and occupational exposure. Occupational exposure causes mammalian allergy in veterinarians, laboratory w...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S108112062600267X</guid>
    </item>
    <item>
      <title>Interpreting abnormal severe combined immunodeficiency (SCID) newborn screens</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002723</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 278-279 | Katz, Alexis R., DO, MSc; Ward, Brant R., MD, PhD&lt;br/&gt;The introduction of newborn screening (NBS) for severe combined immunodeficiency (SCID) marked a revolution in the management of children with the disease and expanded our understanding of the epidemiology in unexpected ways. First introduced as a...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002723</guid>
    </item>
    <item>
      <title>Refining pediatric eczema severity assessment with Three-Item Severity score and Patient-Oriented Eczema Measure</title>
      <link>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002930</link>
      <description>Annals of Allergy, Asthma &amp; Immunology, Volume 137, Issue 3, 2026 Sep, Pages 396-397 | Tsai, Serena Yun-Chen, MD, MMSc; Atwal, Sanmeet, MD; Ong, Peck Y., MD&lt;br/&gt;Children with atopic dermatitis (AD) often struggle with impaired daily functioning, persistent itch, emotional distress, and disturbed sleep. These impacts highlight the importance of the patient perspective in assessing disease severity. Yet, ex...</description>
      <guid>https://www.clinicalkey.com/playContent/1-s2.0-S1081120626002930</guid>
    </item>
  </channel>
</rss>
